Insider trading

Period: 120 months Stock: ALEC + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

180 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

180 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

180 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

180 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
180 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
180 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

180 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
23 Jan 2020
Oney Sabah Chief Business Officer
Sold, plan not stated
$55.46K 2,200 at 25.21
0.4%
22 Jan 2020
King Robert Chief Development Officer
Sold, plan not stated
$66.03 3 at 22.01
0.0%
21 Jan 2020
King Robert Chief Development Officer
Sold, plan not stated
$330.08K 14,997 at 22.01
2.9%
15 Jan 2020
Paul Robert Chief Medical Officer
Sold, plan not stated
$186.70K 10,000 at 18.67
3.5%
9 Jan 2020
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 3×
$7.41M 379,997 at 19.50
90.7%
Sold half or more
26 Dec 2019
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 3×
$200.88K 10,800 at 18.60
21.2%
24 Dec 2019
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 3×
$1.41M 71,800 at 19.59
63.4%
Sold half or more
23 Dec 2019
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 3×
$1.87M 94,285 at 19.82
65.6%
Sold half or more
20 Dec 2019
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 3×
$6.73M 342,500 at 19.66
85.1%
Sold half or more
17 Dec 2019
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 3×
$17.67M 954,100 at 18.52
90.7%
Sold half or more
13 Dec 2019
Paul Robert Chief Medical Officer
Sold, plan not stated
$200.30K 10,000 at 20.03
3.4%
12 Dec 2019
Oney Sabah Chief Business Officer
Sold, plan not stated
$137.07K 6,810 at 20.13
1.1%
10 Dec 2019
Oney Sabah Chief Business Officer
Sold, plan not stated
$10.01K 500 at 20.01
0.1%
9 Dec 2019
Oney Sabah Chief Business Officer
Sold, plan not stated
$46.16K 2,300 at 20.07
0.4%
6 Dec 2019
Oney Sabah Chief Business Officer
Sold, plan not stated
$103.22K 5,156 at 20.02
0.9%
5 Dec 2019
Oney Sabah Chief Business Officer
Sold, plan not stated
$30.00K 1,500 at 20.00
0.3%
3 Dec 2019
Yu Calvin Vice President, Finance
Sold, plan not stated
$24.08K 1,315 at 18.31
0.7%
15 Nov 2019
Paul Robert Chief Medical Officer
Sold, plan not stated
$159.30K 10,000 at 15.93
3.3%
15 Nov 2019
King Robert Chief Development Officer
Sold, plan not stated
$119.40K 7,500 at 15.92
1.4%
15 Oct 2019
Paul Robert Chief Medical Officer
Sold, plan not stated
$146.80K 10,000 at 14.68
3.2%
20 Sep 2019
Paul Robert Chief Medical Officer
Sold, plan not stated
$80.00K 4,000 at 20.00
1.3%
20 Sep 2019
Oney Sabah Chief Business Officer
Sold, plan not stated
$8.00K 400 at 20.00
0.1%
16 Sep 2019
Paul Robert Chief Medical Officer
Sold, plan not stated
$190.80K 10,000 at 19.08
3.1%
20 Aug 2019
Paul Robert Chief Medical Officer
Sold, plan not stated
$14.66K 916 at 16.00
0.3%
19 Aug 2019
King Robert Chief Development Officer
Sold, plan not stated
$112.50K 7,500 at 15.00
1.4%
19 Aug 2019
Paul Robert Chief Medical Officer
Sold, plan not stated
$17.34K 1,084 at 16.00
0.3%
15 Aug 2019
Paul Robert Chief Medical Officer
Sold, plan not stated
$141.90K 10,000 at 14.19
3.0%
7 Aug 2019
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 2×
$11.64M 650,000 at 17.90
18.0%
11 Feb 2019
ORBIMED ADVISORS LLC Director · indirect
Bought 3×
$7.82M 411,700 at 19.00
4.1%
First buy on file
11 Feb 2019
GORDON CARL L Director · indirect
Bought 3×
$7.82M 411,700 at 19.00
4.1%
First buy on file
Showing 151–180 of 180. ← Newer Page 4 of 4